Dacarbazine and tamoxifen in patients with advanced melanoma: An effective therapy option?

被引：0
|
作者：
Rass, K
Seiter, S
Uhl, K
Petzoldt, D
Tilgen, W
机构：
[1] DEPT DERMATOL,HOMBURG,GERMANY
[2] UNIV SAARLAND,D-6600 SAARBRUCKEN,GERMANY
[3] UNIV HEIDELBERG,DEPT DERMATOL,D-6900 HEIDELBERG,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1170 / 1170
页数：2
相关论文
共 50 条
  • [41] CHEMOIMMUNOTHERAPY OF ADVANCED MALIGNANT-MELANOMA - SEQUENTIAL ADMINISTRATION OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA AFTER INTRAVENOUS DACARBAZINE AND CARBOPLATIN OR INTRAVENOUS DACARBAZINE, CISPLATIN, CARMUSTINE AND TAMOXIFEN
    ATZPODIEN, J
    HANNINEN, EL
    KIRCHNER, H
    FRANZKE, A
    KORFER, A
    VOLKENANDT, M
    DUENSING, S
    SCHOMBURG, A
    CHAITCHIK, S
    POLIWODA, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) : 876 - 881
  • [42] Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine
    D J Propper
    J P Braybrooke
    N C Levitt
    K O’Byrne
    K Christodoulos
    C Han
    D C Talbot
    T S Ganesan
    A L Harris
    British Journal of Cancer, 2000, 82 : 1759 - 1763
  • [43] Does polychemotherapy with dacarbazine, vindesine and cisplatin represent a useful therapeutic alternative in patients with advanced melanoma?
    Seiter, S
    Uhl, K
    Rass, K
    Kratofiel, M
    Petzoldt, D
    Tilgen, W
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1172 - 1172
  • [44] Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine
    Propper, DJ
    Braybrooke, JP
    Levitt, NC
    O'Byrne, KO
    Christodoulos, K
    Han, C
    Talbot, DC
    Ganesan, TS
    Harris, AL
    BRITISH JOURNAL OF CANCER, 2000, 82 (11) : 1759 - 1763
  • [45] Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-α in patients with advanced melanoma
    Vuoristo, MS
    Hahka-Kemppinen, M
    Parvinen, LM
    Pyrhönen, S
    Seppä, H
    Korpela, M
    Kellokumpu-Lehtinen, P
    MELANOMA RESEARCH, 2005, 15 (04) : 291 - 296
  • [46] Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma.
    Guo, Jun
    Cui, Chuan Liang
    Gu, Kangsheng
    Tao, Min
    Xin, Song
    Lin, Tongyu
    Ren, Xiu Bao
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] SEQUENTIAL ADMINISTRATION OF DACARBAZINE AND FOTEMUSTINE IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA - AN EFFECTIVE COMBINATION WITH UNEXPECTED TOXICITY
    AAMDAL, S
    GERARD, B
    BOHMAN, T
    DINCALCI, M
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) : 447 - 450
  • [48] Rechallenge of programmed cell death 1 inhibitor after an interval with dacarbazine treatment may be effective for advanced malignant melanoma
    Kan, Takanobu
    Takahagi, Shunsuke
    Kawai, Mikio
    Matsubara, Daiki
    Tanaka, Akio
    Hide, Michihiro
    JOURNAL OF DERMATOLOGY, 2020, 47 (08): : 907 - 910
  • [49] Dacarbazine (DTIC) plus bevacizumab (B) combination therapy in chemotherapy (CTh)-naive advanced melanoma (MM) patients (pts): A phase II study
    di Pietro, A.
    Ferrucci, P.
    Munzone, E.
    Mosconi, M.
    Gandini, S.
    Pari, C.
    Cataldo, F.
    Verrecchia, F.
    Nole, F.
    Testori, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Effects of interferon-α, verpamil and dacarbazine in the treatment of advanced malignat melanoma
    Andersson, R
    Hofer, PA
    Riklund-Åhlström, K
    Henriksson, R
    MELANOMA RESEARCH, 2003, 13 (01) : 87 - 91
12345